Methylenedioxypropylamphetamine
   HOME

TheInfoList



OR:

3,4-Methylenedioxy-''N''-propylamphetamine (MDPR, "Phantom") is a lesser-known psychedelic drug and a substituted amphetamine. MDPR was first synthesized by Alexander Shulgin. In his book '' PiHKAL'', the minimum dosage is listed as 200 mg, and the duration unknown.MDPR entry in ''PiHKAL''
/ref> MDPR is a promoter; by itself it has almost no effects on the mind, but it promotes the effects of
hallucinogens Hallucinogens are a large, diverse class of psychoactive drugs that can produce altered states of consciousness characterized by major alterations in thought, mood, and perception as well as other changes. Most hallucinogens can be categorize ...
, similarly to the closely related MDPH. Shulgin reported that 160 mg of MDPR strongly enhanced the effects of a small (60 μg) dose of
LSD Lysergic acid diethylamide (LSD), also known colloquially as acid, is a potent psychedelic drug. Effects typically include intensified thoughts, emotions, and sensory perception. At sufficiently high dosages LSD manifests primarily mental, vi ...
, and that similar enhancement of hallucinogenic effect was noted when mixing MDPR with other drugs such as
psilocybin Psilocybin ( , ) is a naturally occurring psychedelic prodrug compound produced by more than 200 species of fungi. The most potent are members of the genus ''Psilocybe'', such as '' P. azurescens'', '' P. semilanceata'', and '' P.&nbs ...
, mescaline,
2C-B 2C-B (4-Bromo-2,5-dimethoxyphenethylamine) is a psychedelic drug of the 2C family. It was first synthesized by Alexander Shulgin in 1974. In Shulgin's book '' PiHKAL'', the dosage range is listed as 12–24 mg. As a recreational drug, 2C-B is so ...
, and
2C-T-7 2C-T-7 is a psychedelic phenethylamine of the 2C family. In his book '' PiHKAL: A Chemical Love Story'', Alexander Shulgin lists the dosage range as 10 to 30 mg. 2C-T-7 is generally taken orally, and produces psychedelic and entactogenic ef ...
. The reason for this synergistic action of MDPR has not been elucidated. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPR other than what is written in ''PiHKAL''.


See also

* Phenethylamine * MDAL * Psychedelic drug


References

{{DEFAULTSORT:Methylenedioxy-N-propylamphetamine, 3,4- Benzodioxoles Psychedelic drugs Substituted amphetamines